Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.
3.

Immune evasion by rabies viruses through the maintenance of blood-brain barrier integrity.

Roy A, Hooper DC.

J Neurovirol. 2008 Oct;14(5):401-11. doi: 10.1080/13550280802235924. Epub 2008 Nov 18.

PMID:
19016377
5.
6.

The production of antibody by invading B cells is required for the clearance of rabies virus from the central nervous system.

Hooper DC, Phares TW, Fabis MJ, Roy A.

PLoS Negl Trop Dis. 2009 Oct 6;3(10):e535. doi: 10.1371/journal.pntd.0000535.

7.

Role of chemokines in the enhancement of BBB permeability and inflammatory infiltration after rabies virus infection.

Kuang Y, Lackay SN, Zhao L, Fu ZF.

Virus Res. 2009 Sep;144(1-2):18-26. doi: 10.1016/j.virusres.2009.03.014. Epub 2009 Apr 5.

8.
9.

Blood-brain barrier changes and cell invasion differ between therapeutic immune clearance of neurotrophic virus and CNS autoimmunity.

Fabis MJ, Phares TW, Kean RB, Koprowski H, Hooper DC.

Proc Natl Acad Sci U S A. 2008 Oct 7;105(40):15511-6. doi: 10.1073/pnas.0807656105. Epub 2008 Sep 30.

10.

Silver-haired bat rabies virus variant does not induce apoptosis in the brain of experimentally infected mice.

Yan X, Prosniak M, Curtis MT, Weiss ML, Faber M, Dietzschold B, Fu ZF.

J Neurovirol. 2001 Dec;7(6):518-27.

PMID:
11704884
11.

Characterization of a unique variant of bat rabies virus responsible for newly emerging human cases in North America.

Morimoto K, Patel M, Corisdeo S, Hooper DC, Fu ZF, Rupprecht CE, Koprowski H, Dietzschold B.

Proc Natl Acad Sci U S A. 1996 May 28;93(11):5653-8.

12.

Sufficient virus-neutralizing antibody in the central nerve system improves the survival of rabid rats.

Liao PH, Yang HH, Chou PT, Wang MH, Chu PC, Liu HL, Chen LK.

J Biomed Sci. 2012 Jun 26;19:61. doi: 10.1186/1423-0127-19-61.

13.

Mannitol treatment is not effective in therapy of rabies virus infection in mice.

Dufkova L, Sirmarova J, Salat J, Honig V, Palus M, Ruzek D, Fooks AR, Mansfield KL, Tordo N, Jochmans D, Neyts J, Martina B, Koraka P, Osterhaus ADME; ASKLEPIOS consortium.

Vaccine. 2017 Dec 20. pii: S0264-410X(17)31781-4. doi: 10.1016/j.vaccine.2017.12.028. [Epub ahead of print]

PMID:
29274698
14.

Intracerebral administration of recombinant rabies virus expressing GM-CSF prevents the development of rabies after infection with street virus.

Wang H, Zhang G, Wen Y, Yang S, Xia X, Fu ZF.

PLoS One. 2011;6(9):e25414. doi: 10.1371/journal.pone.0025414. Epub 2011 Sep 28.

15.

Intravenous inoculation of a bat-associated rabies virus causes lethal encephalopathy in mice through invasion of the brain via neurosecretory hypothalamic fibers.

Preuss MA, Faber ML, Tan GS, Bette M, Dietzschold B, Weihe E, Schnell MJ.

PLoS Pathog. 2009 Jun;5(6):e1000485. doi: 10.1371/journal.ppat.1000485. Epub 2009 Jun 19.

16.

Role of the blood-brain barrier in rabies virus infection and protection.

Wang L, Cao Y, Tang Q, Liang G.

Protein Cell. 2013 Dec;4(12):901-3. doi: 10.1007/s13238-013-3918-8.

17.

Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system.

Wang ZW, Sarmento L, Wang Y, Li XQ, Dhingra V, Tseggai T, Jiang B, Fu ZF.

J Virol. 2005 Oct;79(19):12554-65.

19.

Rabies virus clearance from the central nervous system.

Hooper DC, Roy A, Barkhouse DA, Li J, Kean RB.

Adv Virus Res. 2011;79:55-71. doi: 10.1016/B978-0-12-387040-7.00004-4. Review.

PMID:
21601042
20.

Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus.

Faber M, Li J, Kean RB, Hooper DC, Alugupalli KR, Dietzschold B.

Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11300-5. doi: 10.1073/pnas.0905640106. Epub 2009 Jul 6.

Supplemental Content

Support Center